NCT06828718Active, not recruiting
The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC）
Comparison of the Prognosis and Safety of Different Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma: A National Multicenter Real-World Study(NEO-EC）
Source: ClinicalTrials.gov · Last updated 14 Feb 2025
Brief summary (registry, in English)
The prognosis and safety of patients with locally advanced esophageal squamous cell carcinoma were compared with different neoadjuvant therapy modes in multi-cancer centers in China
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 10 Feb 2025
- Start date
- 1 Jan 2015
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Hebei Medical University Fourth Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06828718
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Jan 2015 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- There are contraindications of immunotherapy or chemoradiotherapy;
- Inability to tolerate or refuse surgery;
Other illness
- Have a history of other malignancies (except for cancer in situ that has been cured and other malignancies that have been cured for more than 5 years);
Other
- Distant metastasis has occurred;
Who the study is looking for
- Age ≥18 years, male or female;
- KPS score (KPS) ≥70;
- Esophageal squamous cell carcinoma confirmed by histopathology;
- Clinical stage cT1b-4aN+M0,T3-4aN0M0;
- Surgical resection was performed after 2\~4 cycles of neoadjuvant therapy.
- Expected survival \> 6 months.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Shijiazhuang | China | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.